Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Cancer vaccines enter a new era of personalized immunotherapy

Cancer vaccines enter a new era of personalized immunotherapy

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

Researchers develop protocol to create functional acinar cells in organoids

Researchers develop protocol to create functional acinar cells in organoids

Bio-detection dogs can sniff out hemangiosarcoma

Bio-detection dogs can sniff out hemangiosarcoma

Atypical mutation offers clues to personalized pancreatic cancer treatment

Atypical mutation offers clues to personalized pancreatic cancer treatment

Lung cancer deaths leveling off for EU women, except in Spain

Lung cancer deaths leveling off for EU women, except in Spain

Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments

Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments

Targeting microRNA communication reverses pancreatic cancer's immune suppression

Targeting microRNA communication reverses pancreatic cancer's immune suppression

Cancer mortality drops 34% as treatments and early detection improve

Cancer mortality drops 34% as treatments and early detection improve

CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma

CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

Digital twin technology guides personalized treatment for brain cancer patients

Digital twin technology guides personalized treatment for brain cancer patients

CNIO study identifies genes linked to pancreatic cancer risk and prognosis

CNIO study identifies genes linked to pancreatic cancer risk and prognosis

Novel antisense oligonucleotide shows promise against aggressive pancreatic cancer

Novel antisense oligonucleotide shows promise against aggressive pancreatic cancer

CT-based quantification of tumor fibrosis guides chemotherapy in pancreatic cancer

CT-based quantification of tumor fibrosis guides chemotherapy in pancreatic cancer

Precision immunotherapy for TRBC2-positive T-cell malignancies

Precision immunotherapy for TRBC2-positive T-cell malignancies

New tool can predict recurrence risk in patients with pancreatic neuroendocrine tumors

New tool can predict recurrence risk in patients with pancreatic neuroendocrine tumors

Blocking a key cell pathway reduces muscle wasting in pancreatic cancer

Blocking a key cell pathway reduces muscle wasting in pancreatic cancer

Frog-derived bacteria offer dual-action anticancer effects and high safety

Frog-derived bacteria offer dual-action anticancer effects and high safety

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.